BIGGER CAPITAL FUND L P - 06 Jan 2025 SCHEDULE 13G Report for AEON Biopharma, Inc. Common Stock, $.0001 par value (AEON)

Quoteable Key Fact

"BIGGER CAPITAL FUND L P disclosed 6.1% ownership in AEON Biopharma, Inc. Common Stock, $.0001 par value (AEON) on 06 Jan 2025."

Quick Takeaways

BIGGER CAPITAL FUND L P filed SCHEDULE 13G for AEON Biopharma, Inc. Common Stock, $.0001 par value (AEON).
Disclosed ownership: 6.1%.
Date of event: 06 Jan 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
BIGGER CAPITAL FUND L P	3.1%	2,450,000	2,450,000	/s/ Michael Bigger	Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC, its general partner
Bigger Capital Fund GP, LLC	3.1%	2,450,000	2,450,000	/s/ Michael Bigger	Michael Bigger, Managing Member
District 2 Capital Fund LP	3.1%	2,450,000	2,450,000	/s/ Michael Bigger	Michael Bigger, Managing Member of District 2 GP LLC, its general partner
District 2 Capital LP	3.1%	2,450,000	2,450,000	/s/ Michael Bigger	Michael Bigger, Managing Member
District 2 GP LLC	3.1%	2,450,000	2,450,000	/s/ Michael Bigger	Michael Bigger, Managing Member
District 2 Holdings LLC	3.1%	2,450,000	2,450,000	/s/ Michael Bigger	Michael Bigger, Managing Member
Bigger Michael	6.1%	4,900,000	4,900,000	/s/ Michael Bigger	Michael Bigger